ANTH | Anthera Pharmaceuticals, Inc.
Category: Company
Industry: Drug Manufacturers - Major Quick infos Headquarters: Hayward, California, United States Trade prices Volume: Market Cap: 1.75M Prev closed: 0.063 Open: 0.054 High: 0.066 Low: 0.054 52 week low: 0.007 52 week high: 0.32 Dividends: No Dividends Next ER: March 21, 2023 After Market Closes
About the Company Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat serious conditions associated with cystic fibrosis, inflammation and autoimmune diseases.
Earnings History Date EPS / Forecast Revenue / Forecast May 11, 2023 March 7, 2023 - / - - / - November 22, 2022 - / - - / - November 7, 2022 - / - - / - August 16, 2022 - / - - / - view more
Historical Data Date Price Open High Low Vol Change ER Aug 5, 2022 0.000 0.000 0.000
0.000
0.31K 0% Aug 4, 2022 0.000 0.000 0.000
0.000
4.00K 0% Jul 29, 2022 0.000 0.000 0.000
0.000
3.75K 0% Jul 27, 2022 0.000 0.000 0.000
0.000
2.00K 0% Jul 21, 2022 0.000 0.000 0.000
0.000
49.22K 0% Jul 12, 2022 0.000 0.000 0.000
0.000
1.36K 0% Jun 9, 2022 0.000 0.000 0.000
0.000
0.19K 0% Apr 8, 2022 0.000 0.000 0.000
0.000
18.65K 0% Mar 1, 2022 0.000 0.000 0.000
0.000
0.50K 0% Dec 31, 2021 0.000 0.001 0.001
0.000
83.85K 0% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company ISIN: US03674U1025 CUSIP: 03674U102 Founded:2004 Employees:21 News
Breakeven On The Horizon For Anthera Pharmaceuticals Inc (NASDAQ:ANTH) finance.yahoo.com Apr 10, 2019 5:04 pm
Did Anthera Pharmaceuticals Inc's (NASDAQ:ANTH) Recent Earnings Growth Beat The Trend? finance.yahoo.com Mar 23, 2019 5:03 pm Anthera Fails Phase 3 Study, Time To Avoid - Seeking Alpha seekingalpha.com Mar 16, 2019 8:03 am Anthera Pharmaceuticals (ANTH) Reports Top Line Data From The RESULT Phase 3 Clinical Study Of Sollpura - Slideshow seekingalpha.com Mar 13, 2019 7:03 pm Anthera to explore options after lead drug fails trial, shares slump reuters.com Mar 13, 2019 7:03 pm
Is Anthera Dead in the Water? msn.com Mar 13, 2019 7:03 pm Anthera Pharmaceuticals' stock plunges toward record low after failed drug trial - MarketWatch marketwatch.com Mar 12, 2019 6:03 pm
Mid-Afternoon Market Update: BlueLinx Surges On Cedar Creek Acquisition; Anthera Pharmaceuticals Shares Plunge - Benzinga benzinga.com Mar 12, 2019 6:03 pm
Anthera Pharmaceuticals' stock plunges toward record low after failed drug trial finance.yahoo.com Mar 12, 2019 9:03 am Anthera to explore options after lead drug's trial failure cnbc.com Mar 12, 2019 9:03 am
Anthera Pharmaceuticals to Present at the 30TH Annual ROTH Conference - GlobeNewswire (press release) globenewswire.com Mar 8, 2019 8:03 am Pig out: How an East Bay drug maker is betting on porcine-less disruption of cystic fibrosis - San Francisco Business Times bizjournals.com Mar 8, 2019 8:03 am BRIEF-Anthera Pharma Files For Mixed Shelf Of Up To $100 Million reuters.com Mar 7, 2019 6:03 pm
Anthera Pharmaceuticals Deemed Compliant with Nasdaq Listing Criteria - GlobeNewswire (press release) globenewswire.com Mar 7, 2019 8:03 am
Anthera Pharmaceuticals Provides Business Update and Reports 2017 Fourth Quarter and Fiscal Year Financial Results - GlobeNewswire (press release) globenewswire.com Mar 6, 2019 8:03 am Glomerulonephritis - Pipeline Insights, 2019 - ResearchAndMarkets.com - Business Wire businesswire.com Feb 28, 2019 7:02 pm
Implied Volatility Surging for Anthera Pharmaceuticals (ANTH) Stock Options - Nasdaq nasdaq.com Feb 27, 2019 8:02 am
Technical Perspectives on Biotech Stocks -- AnaptysBio, Anthera Pharma, Aralez Pharma, and Aratana Therapeutics - PR Newswire (press release) prnewswire.com Feb 23, 2019 8:02 am This company doesn't provide a dividend.
Talk about Anthera Pharmaceuticals, Inc. below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
